EVEREST ORGANICS
Back to Income Statement
|
EVEREST ORGANICS Last 5 Year Operating Profit History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹7.18 Cr | ₹11 Cr | ₹0.93 Cr | ₹6.43 Cr | ₹23 Cr |
What is the latest Operating Profit of EVEREST ORGANICS ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹7.18 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹0.93 Cr |
| Mar2022 | ₹6.43 Cr |
| Mar2021 | ₹23 Cr |
How is Operating Profit of EVEREST ORGANICS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.18 Cr | -34.67 | |
| Mar2024 | ₹11 Cr | 1,081.40 | |
| Mar2023 | ₹0.93 Cr | -85.53 | |
| Mar2022 | ₹6.43 Cr | -71.86 | |
| Mar2021 | ₹23 Cr | - | |
Compare Operating Profit of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹222.5 Cr | -2.3% | -8.1% | -41.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -2.3% |
-8.1% |
-41.4% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses